1 New Drug Expected For Patients With Low HER2 Expression, FDA Grants Priority Review Status To Enhertu Jul 04, 2023
Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers Nov 03, 2024
Read More Apparatus "New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial Nov 10, 2024
Read More Medical New Targeted Radiotherapy For "Laser-Like" Precision Treatment Of Refractory Prostate Cancer With Fewer Side Effects! Nov 13, 2024
Read More Medical New Treatment For Childhood Brain Tumours, Tovorafenib, Shows Promising Results With An Efficiency Rate Of 91%! Nov 04, 2024
